
当前,奢侈品行业正面临多重挑战:一方面,中东地区的军事冲突导致高收入群体纷纷逃离该地区,消费欲望随之收紧;另一方面,AI和GLP-1类减肥药的兴起,既让消费者比以往任何时候都更容易触及高端品牌,也催生了新的消费动机。
全球咨询公司贝恩公司(Bain & Co)最新发布的《奢侈品市场监测》(Luxury Monitor)显示,奢侈品行业销售额同比小幅下滑1%;按固定汇率计算,2026年第一季度的跌幅预计为3%。
不过,行业也显现出一些积极信号。贝恩公司高级合伙人克劳迪娅·达尔皮齐奥和费代丽卡·莱瓦托在报告中指出,服用GLP-1减肥药正成为推动消费的重要因素。莱瓦托在接受《财富》杂志采访时表示,这一趋势的兴起“是一个非常核心的问题。从社会学和人类学角度来看,无论是奢侈品行业内部还是其他领域,众多品类的宏观消费趋势,正是眼下最值得关注的话题。”
莱瓦托解释说,在服装、鞋履等“软奢侈品”领域,“消费者减重成功后,自然会产生‘把衣橱全部换新’的冲动,二者存在直接关联。市场上出现了更强烈的购物狂热……这与消费者信心的提升直接相关。”
不过,莱瓦托所说的“消费者信心”,并非指对经济前景的乐观预期,而是指消费者中盛行的一种“YOLO”(人生只有一次)心态。这种心态最初源于疫情结束后的情绪释放,此后,Ozempic、Mounjaro等减肥药又为人们增强自信提供了新选择。
对于奢侈品牌而言,这也带来了诸多待解难题。莱瓦托指出,行业目前面临的核心挑战是如何跨越年龄、地域和收入阶层来扩大客户群体。此外,GLP-1类药物的广泛使用还可能带来另一个影响:越来越多消费者能够穿上奢侈品牌有时尺码选择偏少的服装。
奢侈品牌的服装尺码缩水
即便撇开高昂的财富门槛不谈,长期以来,奢侈品行业一直因缺乏包容性而备受诟病。而在减肥药风靡的当下,针对不同体型消费者的包容性似乎进一步倒退。Vogue Business今年3月发布的《2026秋冬尺码包容性报告》显示,在当季发布的近8,000套造型中,97.6%采用的是美国0至4码的所谓“标准尺码”;美国6至12码的“中间尺码”(mid-size)仅占2.1%;而美国14码及以上的“大码”占比低至0.3%。
该数据比上一季有所下降。上一季,中间尺码占比为2%(过去三个季度基本持平),大码则占0.9%。这意味着,大码服装的占比再次降至2025年秋冬系列(FW25)的水平,也是Vogue Business开始追踪尺码包容性三年以来的最低水平。
莱瓦托指出,尽管尺码包容性涉及伦理层面的考量,但GLP-1减肥药的普及,确实为奢侈品牌带来了新的市场机遇。
她还强调,奢侈品行业需要考虑的另一个趋势,是“轻奢”品牌的崛起。“过去两三年,许多奢侈品牌几乎只盯着最富有的1%消费者……却没有充分挖掘绝大多数消费者所在市场的价值。”
她表示:“新一轮潜在消费者浪潮正席卷而来,但品牌能否敏锐察觉并抓住机会,最终还是取决于它们自己。如果它们继续涨价,无异于主动分流掉这部分消费者。相比之下,其他一些品牌,尤其是美国品牌,则善于挖掘这部分消费者的潜力……它们不仅提供更丰富的尺码选择,价格也更加亲民,因此更容易赢得消费者的认可和青睐。”
品质重于数量
GLP-1减肥药带来的影响还延伸到了高端消费体验。莱瓦托指出,以餐饮行业为例,虽然食客食量下降,但消费偏好同步转向了品质更高的餐食。
莱瓦托强调:“餐饮品牌纷纷推出份量更小、但内在价值更高的产品。消费者买得更少了,但最终客单价持平。这并不是因为品牌提高了利润率,而是因为它们在更小的份量中,注入了更高的品质。”(财富中文网)
译者:刘进龙
审校:汪皓
当前,奢侈品行业正面临多重挑战:一方面,中东地区的军事冲突导致高收入群体纷纷逃离该地区,消费欲望随之收紧;另一方面,AI和GLP-1类减肥药的兴起,既让消费者比以往任何时候都更容易触及高端品牌,也催生了新的消费动机。
全球咨询公司贝恩公司(Bain & Co)最新发布的《奢侈品市场监测》(Luxury Monitor)显示,奢侈品行业销售额同比小幅下滑1%;按固定汇率计算,2026年第一季度的跌幅预计为3%。
不过,行业也显现出一些积极信号。贝恩公司高级合伙人克劳迪娅·达尔皮齐奥和费代丽卡·莱瓦托在报告中指出,服用GLP-1减肥药正成为推动消费的重要因素。莱瓦托在接受《财富》杂志采访时表示,这一趋势的兴起“是一个非常核心的问题。从社会学和人类学角度来看,无论是奢侈品行业内部还是其他领域,众多品类的宏观消费趋势,正是眼下最值得关注的话题。”
莱瓦托解释说,在服装、鞋履等“软奢侈品”领域,“消费者减重成功后,自然会产生‘把衣橱全部换新’的冲动,二者存在直接关联。市场上出现了更强烈的购物狂热……这与消费者信心的提升直接相关。”
不过,莱瓦托所说的“消费者信心”,并非指对经济前景的乐观预期,而是指消费者中盛行的一种“YOLO”(人生只有一次)心态。这种心态最初源于疫情结束后的情绪释放,此后,Ozempic、Mounjaro等减肥药又为人们增强自信提供了新选择。
对于奢侈品牌而言,这也带来了诸多待解难题。莱瓦托指出,行业目前面临的核心挑战是如何跨越年龄、地域和收入阶层来扩大客户群体。此外,GLP-1类药物的广泛使用还可能带来另一个影响:越来越多消费者能够穿上奢侈品牌有时尺码选择偏少的服装。
奢侈品牌的服装尺码缩水
即便撇开高昂的财富门槛不谈,长期以来,奢侈品行业一直因缺乏包容性而备受诟病。而在减肥药风靡的当下,针对不同体型消费者的包容性似乎进一步倒退。Vogue Business今年3月发布的《2026秋冬尺码包容性报告》显示,在当季发布的近8,000套造型中,97.6%采用的是美国0至4码的所谓“标准尺码”;美国6至12码的“中间尺码”(mid-size)仅占2.1%;而美国14码及以上的“大码”占比低至0.3%。
该数据比上一季有所下降。上一季,中间尺码占比为2%(过去三个季度基本持平),大码则占0.9%。这意味着,大码服装的占比再次降至2025年秋冬系列(FW25)的水平,也是Vogue Business开始追踪尺码包容性三年以来的最低水平。
莱瓦托指出,尽管尺码包容性涉及伦理层面的考量,但GLP-1减肥药的普及,确实为奢侈品牌带来了新的市场机遇。
她还强调,奢侈品行业需要考虑的另一个趋势,是“轻奢”品牌的崛起。“过去两三年,许多奢侈品牌几乎只盯着最富有的1%消费者……却没有充分挖掘绝大多数消费者所在市场的价值。”
她表示:“新一轮潜在消费者浪潮正席卷而来,但品牌能否敏锐察觉并抓住机会,最终还是取决于它们自己。如果它们继续涨价,无异于主动分流掉这部分消费者。相比之下,其他一些品牌,尤其是美国品牌,则善于挖掘这部分消费者的潜力……它们不仅提供更丰富的尺码选择,价格也更加亲民,因此更容易赢得消费者的认可和青睐。”
品质重于数量
GLP-1减肥药带来的影响还延伸到了高端消费体验。莱瓦托指出,以餐饮行业为例,虽然食客食量下降,但消费偏好同步转向了品质更高的餐食。
莱瓦托强调:“餐饮品牌纷纷推出份量更小、但内在价值更高的产品。消费者买得更少了,但最终客单价持平。这并不是因为品牌提高了利润率,而是因为它们在更小的份量中,注入了更高的品质。”(财富中文网)
译者:刘进龙
审校:汪皓
The luxury sector is weathering crosswinds at the moment: On the one hand, military conflict in the Middle East has sent high-earning consumers scattering from the region and purse strings tightening. On the other hand, the emergence of AI and weight-loss medication like GLP-1s means it’s never been so easy for consumers to shop for premium brands, and they have an emerging motivation to do so.
The latest Luxury Monitor from global consulting firm Bain & Co shows growth in the sector has dipped slightly (by -1%) year on year, with estimates for Q1 2026 coming in at -3% on a constant exchange rate.
That said, there are green shoots: A major driver of consumption is the use of GLP-1 weight-loss medications, the report authored by Claudia D’Arpizio and Federica Levato, senior partners at Bain & Co, says. The emergence of the trend “is a very central question, and the macro trend in consumption of so many categories within luxury and outside of luxury, from a sociological and anthropological perspective, is the most interesting topic right now,” Levato told Fortune.
In the soft luxury category, like apparel and footwear, “there is, of course, the enthusiasm of having lost weight and so there is a direct correlation with ‘Let’s buy a new wardrobe,'” Levato explains. “There is more enthusiasm for a shopping frenzy … and it’s directly related to higher consumer confidence.”
Levato isn’t talking about consumer confidence in the sense of a brighter economic outlook. Rather, she describes the “YOLO” (you only live once) sentiment among consumers, inspired at first by the end of the pandemic and, since then, new options for self-confidence courtesy of drugs like Ozempic and Mounjaro.
For brands, this raises several questions. Levato suggests the key problem facing the luxury sector is how to broaden its client base, be it by generation, region, or income level. Another effect of widespread use of GLP-1s is that more people may fit the sometimes-limited sizing options offered by luxury brands, Levato says.
Luxury brands are shrinking their clothing size ranges
The luxury sector has long been criticized for not being inclusive (wealth barriers aside). In the era of weight loss drugs, representation for a range of body types appears to have regressed even further. The Vogue Business Fall/Winter 2026 Size Inclusivity Report, released in March, found that of the nearly 8,000 looks presented in the season, 97.6% were in so-called “straight sizes” of U.S. 0-4. The “mid-size” category (U.S. 6-12) had representation of 2.1%, while plus-sizes (U.S. 14+) were just 0.3%.
That’s down on last season, when mid-size looks made up 2% (which is roughly flat for the past three seasons), and plus-size looks made up 0.9%. As such, plus-size representation has dipped to the same level as FW25, the lowest level since Vogue Business began tracking size inclusivity three years ago.
Despite ethical considerations around inclusivity, GLP-1 use presents an opportunity for luxury brands, Levato points out.
Another consideration for the luxury sector is the emergence of affordable luxury brands, she highlights: “Brands in the last two or three years they have focused primarily on top 1% [of wealth] … they are not capitalizing on the value of the market where there is the vast majority.
“There is a huge wave of new potential customers, but it’s really in the hands of the brands to realize that this is coming or not, because if they keep increasing prices, they will cut out some part of the population. Other brands, and namely U.S.-based brands, are very good at doing this … being more accessible for sizes, but also for price points, and this remains in the minds and in the hearts of the consumers.”
Quality vs quantity
The GLP-1 factor also extends to luxury experiences. Levato signals that in restaurants, for example, diners are eating less but are shifting to higher-quality dining at the same time.
“Food brands are really doing smaller packages but with a higher intrinsic value of what they sell,” Levato highlights. “So I buy less, the price in the end is not moving, but not because the margin is higher for brands but because they put more quality into smaller portions.”